BBK Worldwide^® Blog

DPharm. It's one of my favorite conferences that I look forward to each year. This year we will be virtual September 22-23, but still the same great energy and excitement. DPharm is a standout event that challenges and reports on innovation, with the goal of shaking up the way we conduct clinical trials so that we can reduce patient / physician burden and create greater efficiencies.

As the director and one of the producers of Pharma15 Live! I wanted to share with you some insights into what we’ve learned through an amazing three seasons! First of all, if you were to tell me at the beginning of our series that it would even last three seasons, I’d tell you I’d be shocked – but nonetheless here we are and it’s been great!

Ensuring Successful Enrollment of Your Clinical Trials

The market has never been more competitive for small- and mid-size biopharmaceutical companies. While your company may not have the resources or depth of experience as the larger companies, with the right strategies you can find yourself better positioned to deliver results faster and with less expense to reach your clinical trial enrollment goals.

In this free, downloadable ebook, we offer solutions 

For those of us in the clinical R&D industry, this is among the most exciting (and busiest) times of the year. I’m talking, of course, about the Drug Information Association (DIA) Annual Meeting, June 24-28 in Boston.

With industry stakeholders gathering in our own backyard to exchange ideas in the pursuit of developing new therapies and accelerating efforts to enhance health and well-being, we could not be more thrilled. Ask anyone who has attended the DIA in the past, and they will tell you that it’s an occasion where a lot of exciting work gets done in a very short period of time.

Every year that we attend the DIA, we do our best to honor the spirit of the occasion and to acknowledge the importance of our industry colleagues working together in such a dynamic setting. This year, it is our goal to provide an experience that demonstrates our commitment to the patients who make clinical research possible.

When it comes to clinical trial advertising, is “the juice worth the squeeze,” so to speak? To get at the heart of this issue, BBK Worldwide is bringing together industry experts to square off on the live video stream debate “Does Clinical Trial Advertising Deliver?” 

Join us on March 28^th at 1:00pm EDT for a live 15-minute showdown between experts, debating the timely topic of direct-to-consumer advertising to support clinical trial recruitment.

With this lineup, you will not want to miss it!

Four years ago, my colleague and management team member here at BBK Worldwide, Rob Laurens, wrote the blog post, “How a Poster Enrolled my Clinical Trial.” I re-read it recently and thought it would be fun to look back on this article to see how our ideas about patient engagement and enrollment may have changed over the last few years thanks to technology and the rise of mHealth.

At last, patient centricity is much more than an industry buzzword. We’re seeing real efforts to put patients at the center of clinical research, and it’s beginning to impact all areas across the clinical research continuum.

On the heels of our recent post on our presence at this week’s DIA Japan 2015, BBK welcomes Philip Gregory, the General Manager of George Clinical - CRO China as our guest contributor. With more than 20 years of experience in pharmaceutical, biotech and medical device marketing, Mr. Gregory has spent over 14 years supporting the expansion of clinical trial capabilities in Asia. He will be providing his insights over the course of a three-part blog series on the growth of clinical research across the Asia Pacific region.

Partnering with advocacy groups is a vital component to any clinical trial outreach effort. The approach to working with advocacy groups has changed in recent years. It is not just about the one connection you may have with one organization. These days it’s about working with the condition community as a whole for one common goal. Advocacy groups often have direct connections to people affected by a condition and can be highly beneficial to enrollment throughout the patient recruitment process.

Pew Research Center indicates that 87 percent of Americans are using the Internet regularly.  With social and digital media becoming ever-more prevalent, it makes sense that within the clinical trial industry, researchers are now looking to it as a way to control some of the escalating R&D costs and make the process more patient-centric.